Agramunt, S., Grigg, J., & Lenton, S. (2020). Western Australia Drug Trends 2019: Key findings from the Illicit Drug Reporting System (IDRS) Interviews. Australian Drug Trends. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney. Retrieved from http://doi.org/10.26190/5e46010d02d2b

Arunogiri, S., & Nielsen, S. (2020). Opioid agonist treatment in the time of fentanyl: What can we learn from emerging evidence? Drug and Alcohol Review, 39(3), 203-204. doi:10.1111/dar.13029

Black, N., Campbell, G., Tran, L. T., Farrell, M., Hall, W., & Degenhardt, L. (2020). Cannabinoids for the treatment of mental disorders – Author's reply. The Lancet Psychiatry, 7(2), 127-128. doi:10.1016/S2215-0366(19)30526-7

Bórquez, A., Rich, K., Farrell, M., Degenhardt, L., McKetin, R., Tran, L. T., . . . Martin, N. K. (2020). Integrating HIV pre-exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study. Journal of the International AIDS Society, 23(S1). doi:10.1002/jia2.25495

Borschmann, R., Tibble, H., Spittal, M. J., Preen, D., Pirkis, J., Larney, S., Rosen, D. L., Young, J. T., Love, A. D., Altice, F. L., . . . Degenhardt, L., Dirkzwager, A. J. E., Dolan, K., . . . Kinner, S. A. The Mortality after Release from Incarceration Consortium (MARIC): Protocol for a multi-national, individual participant data meta-analysis. International Journal of Population Data Science, 5(1). doi:10.23889/ijpds.v5i1.1145

Campbell, G., Darke, S., Degenhardt, L., Townsend, H., Carter, G., Draper, B., Farrell, M., Duflou, J., & Lappin, J. (2020). Prevalence and characteristics associated with chronic noncancer pain in suicide decedents: A national study. Suicide and Life-Threatening Behavior. doi:10.1111/sltb.12627

Chambers, G. M., Settumba, S. N., Carey, K. A., Cairns, A., Menezes, M. P., Ryan, M., & Farrar, M. A. (2020). Prenusinersen economic and health-related quality of life burden of spinal muscular atrophy. Neurology, 95(1), e1-e10. doi:10.1212/WNL.0000000000009715

Childs, A., Coomber, R., Bull, M., & Barratt, M. J. (2020). Evolving and diversifying selling practices on drug cryptomarkets: An exploration of off-platform “direct dealing”. Journal of Drug Issues, 50(2), 173-190. doi:10.1177/0022042619897425

Ciupka, B., & Dietze, P. (2020). Victorian Drug Trends 2019: Key findings from the Ecstasy and Related Drugs Reporting System (EDRS) Interviews. Australian Drug Trends. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney. Retrieved from http://doi.org/10.26190/5e45fea61683f

Colledge, S., Leung, J., Grebely, J., Degenhardt, L., Peacock, A., Hickman, M., . . . Larney, S. (2020). Socio-demographic and ecological factors associated with anti-HCV prevalence in people who inject drugs: A systematic review. Drug and Alcohol Dependence, 209. doi:10.1016/j.drugalcdep.2020.107899

Connolly, D., Davies, E., Lynskey, M., Barratt, M. J., Maier, L., Ferris, J., . . . Gilchrist, G. (2020). Comparing intentions to reduce substance use and willingness to seek help among transgender and cisgender participants from the Global Drug Survey. Journal of Substance Abuse Treatment, 112, 86-91. doi:10.1016/j.jsat.2020.03.001

Couto e Cruz, C., Salom, C., Parsell, C., Dietze, P., Burns, L., & Alati, R. (2020). Social domains of discrimination against people who inject drugs: Links with health and wellbeing. International Journal of Drug Policy, 77. doi:10.1016/j.drugpo.2019.102620